Mumbai-based drugmaker Lupin Ltd on Friday said it is planning to invest $600 million over the next few years on acquisitions in India and abroad. Aiming to enhance its presence in the US, Japan and middle east, the company said it plans to acquire 60 per cent equity in South Africa-based Pharma Dynamics.
